CRCLE DICLOFENAC SODIUM TOPICAL GEL 1%- diclofenac sodium topical gel 1% gel 
Innovus Pharmaceuticals Inc.

----------

Diclofenac Sodium Topical Gel, 1%

(NSAID) - arthritis pain reliever

Active ingredient

Diclofenac sodium (NSAID*) 1% (equivalent to 0.93% diclofenac)

*nonsteroidal anti-inflammatory drug

Purpose

Arthritis pain reliever

Uses

Warnings

For external use only

Allergy alert: Diclofenac may cause a severe allergic reaction, especially in people allergic to aspirin.

Symptoms may include:

• hives • asthma (wheezing) • skin reddening • blisters • facial swelling • shock • rash

If an allergic reaction occurs, stop use and seek medical help right away.

Liver warning:

This product contains diclofenac. Liver damage may occur if you apply

Stomach bleeding warning:

This product contains an NSAID, which may cause severe stomach bleeding. The chance is small but higher if you

Heart attack and stroke warning:

NSAIDs, except aspirin, increase the risk of heart attack, heart failure, and stroke. These can be fatal. The risk is higher if you use more than directed or for longer than directed.

Do not use

Ask a doctor before use if 

Ask a doctor or pharmacist before use if you are

When using this product

Stop use and ask a doctor if

If pregnant or breast-feeding

ask a health professional before use. It is especially important not to use diclofenac at 20 weeks or later in pregnancy unless definitely directed to do so by a doctor because it may cause problems in the unborn child or complications during delivery.

Keep out of reach of children.

If swallowed, get medical help or contact a Poison Control Center right away.

Directions

Use up to 21 days unless directed by your doctor

Not for strains, sprains, bruises or sports injuries. This product has not been shown to work for these types of injuries.

 Daily Per Dose
 For your arthritis pain:
  • Use 4 times per day every day
  • Do not use on more than 2 body areas at the same time
Use ENCLOSED DOSING CARD to measure a dose
  • For each upper body area (hand, wrist, or elbow) – Squeeze out 2.25 inches (2 grams)
  • For each lower body area (foot, ankle or knee) –Squeeze out 4.5 inches (4 grams)

Read the enclosed User Guide for complete instructions:

Other information

Inactive ingredients

carbomer homopolymer type C, cocoyl caprylocaprate, ispropyl alcohol, mineral oil, polyoxyl 20 cetostearyl ether, propylene glycol, purified water, strong ammonia solution.

Question and comments?

1-833-285-4151

Carton

NDC 57483-596-01

ORIGINAL PRESCRIPTION STRENGTH

Crcle Diclofenac Sodium Topical Gel, 1% 

(NSAID)- Arthritis pain reliever

Anti-inflammatory

For daily treatment of arthritis pain

FOR EXTERNAL USE ONLY

Compare to the active ingredient in Voltaren Arthritis Pain Gel**
NET WT 5.29 oz (150 g)

image description

CRCLE DICLOFENAC SODIUM TOPICAL GEL 1% 
diclofenac sodium topical gel 1% gel
Product Information
Product TypeHUMAN OTC DRUGItem Code (Source)NDC:57483-596
Route of AdministrationTOPICAL
Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
DICLOFENAC SODIUM (UNII: QTG126297Q) (DICLOFENAC - UNII:144O8QL0L1) DICLOFENAC SODIUM10 mg  in 1 g
Inactive Ingredients
Ingredient NameStrength
CARBOMER HOMOPOLYMER TYPE C (UNII: 4Q93RCW27E)  
COCO-CAPRYLATE/CAPRATE (UNII: 8D9H4QU99H)  
ISOPROPYL ALCOHOL (UNII: ND2M416302)  
MINERAL OIL (UNII: T5L8T28FGP)  
POLYOXYL 20 CETOSTEARYL ETHER (UNII: YRC528SWUY)  
PROPYLENE GLYCOL (UNII: 6DC9Q167V3)  
WATER (UNII: 059QF0KO0R)  
AMMONIA (UNII: 5138Q19F1X)  
Packaging
#Item CodePackage DescriptionMarketing Start DateMarketing End Date
1NDC:57483-596-011 in 1 CARTON03/31/2023
1150 g in 1 TUBE; Type 0: Not a Combination Product
Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
ANDAANDA21098601/10/2022
Labeler - Innovus Pharmaceuticals Inc. (962507187)

Revised: 3/2023
Document Id: 59143e11-f5ea-462d-a283-929ece6ba550
Set id: b373c202-5795-418f-989c-1ec5837145af
Version: 1
Effective Time: 20230324
 
Innovus Pharmaceuticals Inc.